ID: ALA5267475

Max Phase: Preclinical

Molecular Formula: C18H22N4

Molecular Weight: 294.40

Associated Items:

Representations

Canonical SMILES:  CN1CCN(c2ccc(/C=N/Nc3ccccc3)cc2)CC1

Standard InChI:  InChI=1S/C18H22N4/c1-21-11-13-22(14-12-21)18-9-7-16(8-10-18)15-19-20-17-5-3-2-4-6-17/h2-10,15,20H,11-14H2,1H3/b19-15+

Standard InChI Key:  SHZWMGOYFVBFCQ-XDJHFCHBSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.40Molecular Weight (Monoisotopic): 294.1844AlogP: 2.88#Rotatable Bonds: 4
Polar Surface Area: 30.87Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.90CX LogP: 3.76CX LogD: 2.98
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.69Np Likeness Score: -1.65

References

1. Manzoor S, Hoda N..  (2020)  A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.,  206  [PMID:32942081] [10.1016/j.ejmech.2020.112787]

Source